Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bortezomib advanced mechanisms of action in multiple myeloma, solid and liquid tumors along with its novel therapeutic applications.
Mohammad Alwahsh, Joviana Farhat, Shahd Talhouni, et al.
PubMed (2023) Vol. 22, pp. 146-168
Closed Access | Times Cited: 19

Showing 19 citing articles:

NF-κB in biology and targeted therapy: new insights and translational implications
Qing Guo, Yizi Jin, Xinyu Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 451
Advancements in Multiple Myeloma Therapies: A Comprehensive Review by Disease Stage
Hager Hisham El Khatib, Хамдан Абдулла, Layla Khaled Nassar, et al.
Lymphatics (2025) Vol. 3, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
Understanding the molecular bridges between the drugs and immune cell
Umesh Chandra Dash, Vinayak Nayak, Hiten Shanker Navani, et al.
Pharmacology & Therapeutics (2025) Vol. 267, pp. 108805-108805
Open Access | Times Cited: 1
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development
Pralay Mukhopadhyay, Hesham Abdullah, Joanna Opalinska, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
WTAP and m6A-modified circRNAs modulation during stress response in acute myeloid leukemia progenitor cells
Alessia Iaiza, Gilla Mazzanti, Frauke Goeman, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 4
Comprehensive Analysis Identifies Hsa_circ_0058191 as a Potential Drug Resistance Target in Multiple Myeloma
Huiye Yang, Jie Zhu, Xiaotao Wang
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 225-231
Open Access
Carfilzomib inhibits the progression of hepatocellular cancer by upregulating GADD45α expression
Mingxun Chen, Chen Xu, Yifang Shui, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-14
Open Access
Influence of PSMB6 and PSMB9 Genetic Polymorphisms on Bortezomib-Based Therapy Response in Newly Diagnosed Multiple Myeloma
N N Sood, Abdoul Hamide, Biswajit Dubashi, et al.
Cureus (2025)
Open Access
Nanoparticle Albumin-Bound Bortezomib: Enhanced Antitumor Efficacy and Tumor Accumulation in Breast Cancer Therapy
Anita Saremi Poor, Bagher Davaeil, Mahnaz Ramezanpour, et al.
Molecular Pharmaceutics (2025)
Closed Access
The Efficacy of Carfilzomib Treatment in Bortezomib-Refractory Patients—Real Life Experience in a Tertiary Romanian Hospital
Ruxandra Irimia, Sorina Bădeliță, Sinziana Barbu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2171-2171
Open Access | Times Cited: 2
Anti-COVID Drugs (MMV COVID Box) as Leishmanicidal Agents: Unveiling New Therapeutic Horizons
Atteneri López‐Arencibia, Carlos J. Bethencourt-Estrella, Desirée San Nicolás-Hernández, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 266-266
Open Access | Times Cited: 2
Gammopathic dermopathy: characterization of cutaneous MGUS
Emily R. Gordon, Caroline Chen, Megan H. Trager, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 7, pp. 989-996
Closed Access | Times Cited: 1
Targeting chaperone modifications: Innovative approaches to cancer treatment
Mariah Stewart, Jonathan C. Schisler
Journal of Biological Chemistry (2024), pp. 107907-107907
Open Access | Times Cited: 1
Chemotherapy Resistance in Cancer: Mechanism and Roadmap to Evade Exploring Apoptosis
Kalpataru Halder
International Journal of Advancement in Life Sciences Research (2024) Vol. 07, Iss. 02, pp. 17-40
Open Access
Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia
Dimitra Mavridou, Konstantina Psatha, Michalis Aivaliotis
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 831-831
Open Access
Successful Treatment of Plasma Cell‐Rich Acute Rejection Using Bortezomib: A Case Report
Sara Hashemi, Reut Hod Dvorai, Rebecca Tong, et al.
Case Reports in Transplantation (2024) Vol. 2024, Iss. 1
Open Access
Drug Combination Studies of Isoquinolinone AM12 with Curcumin or Quercetin: A New Combination Strategy to Synergistically Inhibit 20S Proteasome
Carla Di Chio, Santo Previti, Josè Starvaggi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10708-10708
Open Access
Drug classification for the treatment of hematologic malignancies
Svitlana A. Husieva, Olena Ya. Antonyuk, Valeriia Husieva
Elsevier eBooks (2024), pp. 1-52
Closed Access
Three Dimensional Objects Encryption Algorithms: A Review
Manal A. Mizher, Salam Hamdan, Manar Abduljabbar Ahmad Mizher, et al.
(2023), pp. 435-440
Closed Access
Page 1

Scroll to top